In individuals with IGT and T2DM, circulating CTRP7 levels showed an opposite trend to circulating ADIPOQ levels; thus, the increase in CTRP7 levels may represent a compensatory response to decreased ADIPOQ levels or the stimulation of IR and metabolic disorder. Here, C1QTNF7 is linked to metabolic disease.